Want to see HK:2273 full AI Analyst Report?
2273 Stock Chart & Stats
HK$26.44
HK$0.26(0.91%)
At close: 4:00 PM EDT
HK$26.44
HK$0.26(0.91%)
Day’s Range― - ―
52-Week RangeHK$24.32 - HK$32.52
Previous CloseN/A
Volume151.30K
Average Volume (3M)687.41K
Market Cap
HK$6.44B
Enterprise ValueHK$6.54K
Total Cash (Recent Filing)HK$1.29B
Total Debt (Recent Filing)HK$1.53B
Price to Earnings (P/E)12.9
Beta1.23
Next Earnings
Mar 31, 2027EPS Estimate
1.24Next Dividend Ex-DateN/A
Dividend Yield3.77%
Share Statistics
EPS (TTM)1.83
Shares Outstanding234,371,050
10 Day Avg. Volume487,436
30 Day Avg. Volume687,406
Financial Highlights & Ratios
PEG Ratio0.93
Price to Book (P/B)2.83
Price to Sales (P/S)1.89
P/FCF Ratio12.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$41.26Price Target Upside56.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.86
Revenue Forecast (FY)HK$3.73B
Bulls Say, Bears Say
Bulls Say
Rapid Revenue GrowthSustained, accelerating revenue growth indicates strong patient demand and expanding clinic activity. Continued top-line momentum can support operating scale and reinforce Gushengtang’s position in China’s TCM healthcare services market over the medium term.
Sustained ProfitabilityThe post-2021 turnaround has produced several years of positive earnings and stable net margins. This demonstrates that the clinic and TCM medicine model can generate durable profits after recovery, providing a stronger base for continued expansion.
Sound Balance SheetModerate leverage and a growing equity base provide financial capacity to fund operations and expansion. Improving ROE also suggests that management is deploying shareholder capital more effectively, although the recent leverage trend warrants monitoring.
Bears Say
Weaker Free Cash Flow GrowthAlthough free cash flow remains positive and supported by earnings, the sharp 2025 contraction signals weaker cash conversion momentum. If sustained, this could limit internally funded expansion and increase reliance on debt or other financing.
Rising LeverageHigher debt reduces financial flexibility if operating conditions weaken or expansion requires more capital. While current leverage is described as moderate, continued increases could raise funding risk and constrain investment in the clinic network.
Margin VolatilityStable net margins are encouraging, but lower gross margins and uneven EBITDA performance indicate pressure from cost mix or operating leverage. Persistent volatility could limit the conversion of strong revenue growth into proportionate profit growth.
Gushengtang Holdings Limited News
2273 FAQ
What was Gushengtang Holdings Limited’s price range in the past 12 months?
Gushengtang Holdings Limited lowest stock price was HK$24.32 and its highest was HK$32.52 in the past 12 months.
What is Gushengtang Holdings Limited’s market cap?
Gushengtang Holdings Limited’s market cap is HK$6.44B.
When is Gushengtang Holdings Limited’s upcoming earnings report date?
Gushengtang Holdings Limited’s upcoming earnings report date is Mar 31, 2027 which is in 187 days.
How were Gushengtang Holdings Limited’s earnings last quarter?
Gushengtang Holdings Limited released its earnings results on Aug 28, 2026. The company reported HK$0.806 earnings per share for the quarter, missing the consensus estimate of HK$0.935 by -HK$0.129.
Is Gushengtang Holdings Limited overvalued?
According to Wall Street analysts Gushengtang Holdings Limited’s price is currently Undervalued.
Does Gushengtang Holdings Limited pay dividends?
Gushengtang Holdings Limited pays a Semiannually dividend of HK$1.15 which represents an annual dividend yield of 3.77%. See more information on Gushengtang Holdings Limited dividends here
What is Gushengtang Holdings Limited’s EPS estimate?
Gushengtang Holdings Limited’s EPS estimate is 1.24.
How many shares outstanding does Gushengtang Holdings Limited have?
Gushengtang Holdings Limited has 234,371,050 shares outstanding.
What happened to Gushengtang Holdings Limited’s price movement after its last earnings report?
Gushengtang Holdings Limited reported an EPS of HK$0.806 in its last earnings report, missing expectations of HK$0.935. Following the earnings report the stock price went up 8.259%.
Which hedge fund is a major shareholder of Gushengtang Holdings Limited?
Currently, no hedge funds are holding shares in HK:2273
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gushengtang Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.78%
12-Months-Change
Fundamentals
Return on Equity
3.77%
Trailing 12-Months
Asset Growth
18.34%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gushengtang Holdings Limited
Gushengtang Holdings Limited, an investment holding company, provides healthcare services in the People’s Republic of China. The company offers consultation, traditional massage, moxibustion, acupuncture, and other therapies. It is also involved in the wholesale of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. The company was founded in 2010 and is headquartered in Guangzhou, the People’s Republic of China.
2273 Stock 12 Month Forecast
Average Price Target
HK$41.26
▲(56.05% Upside)
Technical Analysis
Beauty Farm Medical & Health Industry, Inc.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―